Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means treating a tumor with more than one type of therapy at the same time ...
Affimed has decided to focus on testing AFM13 in combination with Artiva's AB-101 NK cell product for the treatment of peripheral T-cell lymphoma after underwhelming monotherapy data. Peripheral ...
In studies investigating the combination of two or more anticancer drugs that are already approved for independent use, or 'maintenance' regimens, the use of progression-free survival as the end point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results